These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15464145)

  • 1. Secrets of the opium poppy revealed.
    Evans CJ
    Neuropharmacology; 2004; 47 Suppl 1():293-9. PubMed ID: 15464145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the field of cannabinoid--opioid cross-talk.
    Robledo P; Berrendero F; Ozaita A; Maldonado R
    Addict Biol; 2008 Jun; 13(2):213-24. PubMed ID: 18482431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cell biologist's perspective on physiological adaptation to opiate drugs.
    von Zastrow M
    Neuropharmacology; 2004; 47 Suppl 1():286-92. PubMed ID: 15464144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and cellular basis of cannabinoid and opioid interactions.
    Viganò D; Rubino T; Parolaro D
    Pharmacol Biochem Behav; 2005 Jun; 81(2):360-8. PubMed ID: 15927245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New developments and findings in the field of opiates, opioids, opiate receptors and complete and partial opiate antagonists].
    Schneider M; Bunge HJ; Heinrich F
    Anaesthesiol Reanim; 1990; 15(3):138-44. PubMed ID: 2168183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiate tolerance and dependence: recent findings and synthesis.
    Trujillo KA; Akil H
    New Biol; 1991 Oct; 3(10):915-23. PubMed ID: 1662985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids and reward: interactions with the opioid system.
    Fattore L; Cossu G; Spano MS; Deiana S; Fadda P; Scherma M; Fratta W
    Crit Rev Neurobiol; 2004; 16(1-2):147-58. PubMed ID: 15581410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Opioid receptors in the era of molecular biology: they account for more than 6,000 years of empirical pharmacology].
    Huidobro-Toro JP
    Rev Med Chil; 1995 May; 123(5):628-36. PubMed ID: 8525211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecular basis for opiate action.
    Massotte D; Kieffer BL
    Essays Biochem; 1998; 33():65-77. PubMed ID: 10488442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opiates and plasticity.
    Dacher M; Nugent FS
    Neuropharmacology; 2011 Dec; 61(7):1088-96. PubMed ID: 21272593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bidirectional effects of opioids in motivational processes and the involvement of D1 dopamine receptors.
    Herz A
    NIDA Res Monogr; 1988; 90():17-26. PubMed ID: 2855853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide and nonpeptide ligands for opioid receptors.
    Misicka A
    Acta Pol Pharm; 1995; 52(5):349-63. PubMed ID: 8960271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular actions of opiates: historical overview and new findings on opiate receptor interactions with enkephalins and guanyl nucleotides.
    Snyder SH; Childers SR; Creese I
    Adv Biochem Psychopharmacol; 1979; 20():543-52. PubMed ID: 224663
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression.
    Shook JE; Watkins WD; Camporesi EM
    Am Rev Respir Dis; 1990 Oct; 142(4):895-909. PubMed ID: 2171388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric Modulation of Opioid G-Protein Coupled Receptors by Sigma
    Pasternak GW
    Handb Exp Pharmacol; 2017; 244():163-175. PubMed ID: 28667477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis of opioid receptor function.
    Simonds WF
    Endocr Rev; 1988 May; 9(2):200-12. PubMed ID: 2841104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of delta opioid peptides as nonaddicting analgesics.
    Rapaka RS; Porreca F
    Pharm Res; 1991 Jan; 8(1):1-8. PubMed ID: 1849640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opiate actions and catecholamines.
    Iwamoto ET; Way EL
    Adv Biochem Psychopharmacol; 1979; 20():357-407. PubMed ID: 38641
    [No Abstract]   [Full Text] [Related]  

  • 19. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate receptors and analgesia: an update.
    Hayes SR; Vogelsang J
    J Post Anesth Nurs; 1991 Apr; 6(2):125-8. PubMed ID: 1848890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.